Literature DB >> 12467056

Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma.

Jeanne S Mandelblatt1, Stephen B Edge, Neal J Meropol, Ruby Senie, Theodore Tsangaris, Luther Grey, Burt Peterson, Yi-Ting Hwang, Jane C Weeks.   

Abstract

BACKGROUND: There are few data on the long-term sequelae of axillary dissection among older breast carcinoma patients. We describe the impact of axillary dissection in a cohort of older women.
METHODS: A longitudinal cohort of 571 patients with Stage 1 and 2 breast carcinoma, 67 years and older, diagnosed between 1995 and 1997 from 29 hospitals in five regions, and followed for 2 years. Data were collected from patients and medical charts. The primary outcome was posttreatment quality of life. Generalized estimation equation longitudinal modeling was used to evaluate the outcome, controlling for baseline function, comorbidity, age, clinical status, and other factors.
RESULTS: Sixty percent of women reported arm problems at some time in the 2 years after surgery. The cumulative risk of having arm problems 2 years posttreatment was three times higher (95% confidence interval 1.94-4.67) for women who underwent axillary surgery compared with women without axillary surgery, controlling for covariates. The effects of having axillary dissection and arthritis were multiplicative 2 years postsurgery. Arm problems were, in turn, the primary determinate of lower physical and mental functioning (P = 0.0001 and 0.04, respectively), controlling for other factors. Undergoing axillary dissection did not lessen fears about recurrence.
CONCLUSIONS: Arm problems after axillary dissection have a consistent negative impact on quality of life, suggesting that the risks may outweigh the potential benefits in this population. Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10983

Entities:  

Mesh:

Year:  2002        PMID: 12467056     DOI: 10.1002/cncr.10983

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  The influence of aging on the early detection, diagnosis, and treatment of breast cancer.

Authors:  Marisa F Siebel; Hyman B Muss
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

2.  Risk of decline in upper-body function and symptoms among older breast cancer patients.

Authors:  Jennifer L Westrup; Timothy L Lash; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

3.  Breast cancer in elderly women (≥ 80 years): variation in standard of care?

Authors:  Amy Cyr; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Julie A Margenthaler
Journal:  J Surg Oncol       Date:  2010-11-23       Impact factor: 3.454

4.  Evaluation of a Mammography Screening Decision Aid for Women Aged 75 and Older: Protocol for a Cluster-randomized Controlled Trial.

Authors:  Mara A Schonberg; Christine E Kistler; Larissa Nekhlyudov; Angela Fagerlin; Roger B Davis; Christina C Wee; Edward R Marcantonio; Carmen L Lewis; Whitney A Stanley; Trisha M Crutchfield; Mary Beth Hamel
Journal:  J Clin Trials       Date:  2014

5.  The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment.

Authors:  Jennifer J Griggs; Melony E S Sorbero; Gretchen M Ahrendt; Azadeh Stark; Susanne Heininger; Heather T Gold; Linda M Schiffhauer; Andrew W Dick
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

6.  A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.

Authors:  Jeanne S Mandelblatt; Solomon B Makgoeng; Gheorghe Luta; Arti Hurria; Gretchen Kimmick; Claudine Isaacs; Michelle Tallarico; William T Barry; Brandy Pitcher; Eric P Winer; Clifford Hudis; Harvey J Cohen; Hyman B Muss
Journal:  J Geriatr Oncol       Date:  2013-06-20       Impact factor: 3.599

7.  Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer.

Authors:  A Laws; R Cheifetz; R Warburton; C E McGahan; J S Pao; U Kuusk; C Dingee; M L Quan; E McKevitt
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

8.  Surgical Management of the Axilla in Elderly Women With Node-Positive Breast Cancer.

Authors:  Caitlin E Marks; Yi Ren; Laura H Rosenberger; Samantha M Thomas; Rachel A Greenup; Oluwadamilola M Fayanju; Susan McDuff; Gretchen Kimmick; E Shelley Hwang; Jennifer K Plichta
Journal:  J Surg Res       Date:  2020-05-29       Impact factor: 2.192

Review 9.  Breast cancer management in the elderly.

Authors:  M Luque; F Arranz; J F Cueva; A de Juan; P García-Teijido; L Calvo; I Peláez; A García-Palomo; J García-Mata; S Antolín; L García-Estévez; Y Fernández
Journal:  Clin Transl Oncol       Date:  2013-10-02       Impact factor: 3.405

Review 10.  Outcomes and quality of life following breast cancer treatment in older women: when, why, how much, and what do women want?

Authors:  Jeanne Mandelblatt; Melissa Figueiredo; Jennifer Cullen
Journal:  Health Qual Life Outcomes       Date:  2003-09-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.